Indications and Purposes
| 1 Indications And Usage Bosulif Is Indicated For The Treatment Of Adult Patients With Chronic, Accelerated, Or Blast Phase Philadelphia Chromosome-Positive (Ph+) Chronic Myelogenous Leukemia (Cml) With Resistance Or Intolerance To Prior Therapy. Bosulif Is A Kinase Inhibitor Indicated For The Treatment Of Adult Patients With Chronic, Accelerated, Or Blast Phase Ph+ Chronic Myelogenous Leukemia (Cml) With Resistance Or Intolerance To Prior Therapy. ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Bosutinib Monohydrate |